Table 2. Major series of over ten patients who underwent combined resection of the liver and vena cava for malignancy over the last 15 years, perioperative morbidity and mortality, as well as long-term survival.
| Study (year) | Patients (n) | Method of caval reconstruction | Morbidity (%) | Mortality (%) | Survival (%) | Veno–veno bypass, n (%) | Ref. |
|---|---|---|---|---|---|---|---|
| Miyazaki et al. (1999) | Total: 16 Secondary |
Primary: 13 Patch: 2 Segmental PTFE: 1 |
25 | 6 | 1 year: 64 3 year: 33 5 year: 27 |
3 (19) | [43] |
| Arii et al. (2003) | Total: 11 Primary: 8 Secondary: 3 |
Primary: 1 Patch: 1 Segmental End-to-end: 2 PTFE: 5 |
N/A | 9 | 1 year: 64 3 year: 25 Median: 29 months |
1 (9) | [44] |
| Sarmiento et al. (2003) | Total: 19 Primary: 16 Secondary: 3 |
Segmental End-to-end: 1 PTFE: 18 |
37 | 5 | 1 year: 92 5 year: 21 Median: 38 months |
7 (37) | [46] |
| Nardo et al. (2005) | Total: 19 Primary: 8 Secondary: 11 |
Primary: 12 Patch: 3 Segmental PTFE: 18 |
60 | 11 | 1 year: 79 2 year: 68 5 year: 49 |
0 | [49] |
| Azoulay et al. (2006) | Total: 22 Primary: 13 Secondary: 9 |
Primary: 4 Segmental End-to-end: 8 PTFE: 10 |
64 | 5 | 1 year: 82 3 year: 38 5 year: 38 |
12 (55) | [42] |
| Delis et al. (2007) | Total: 12 Primary: 6 Secondary: 6 |
Segmental PTFE: 12 |
67 | 0 | Four died at mean follow-up of 24 months | 2 (17) | [48] |
| Nuzzo et al. (2011) | Total: 23 Primary: 10 Secondary: 13 |
Primary: 16 Segmental PTFE: 7 |
25 | 4 | 69 at median of 33 months, and 43 without evidence of recurrence | 4 (12.5) | [65] |
| Hemming et al. (2013) | Total: 60 Primary: 44 Secondary: 16 |
Primary: 8 Patch: 14 Segmental PTFE: 38 |
43 | 8 | 1 year: 89 5 year: 35 |
6 (10) all ex vivo |
[41] |
| Pulitano et al. (2013) | Total: 32 (liver resection: 14) Primary: 27 Secondary: 5 |
Patch: 10 Segmental Peritoneo-fascial: 22 |
28 | 9 | 1 year: 78 5 year: 48 |
0 | [66] |
N/A: Not available; PTFE: Polytetrafluoroethylene graft.